Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$947M |
| 2 |
Tesla
TSLA
|
+$608M |
| 3 |
Microsoft
MSFT
|
+$444M |
| 4 |
Accenture
ACN
|
+$409M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.06B |
| 2 |
Texas Instruments
TXN
|
+$1.92B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.81B |
| 4 |
Starbucks
SBUX
|
+$1.42B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1,000M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.52% |
| 2 | Financials | 7.13% |
| 3 | Consumer Discretionary | 6.46% |
| 4 | Healthcare | 5.43% |
| 5 | Communication Services | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3601
Advantage Solutions
ADV
$522M
| $569K | ﹤0.01% |
6,641
+5,055
| +319% | +$466K |
|
|
HDSN
3602
Hudson Technologies
HDSN
$254M
| $569K | ﹤0.01% |
68,191
+51,719
| +314% | +$428K |
|
|
ALLK
3603
DELISTED
Allakos
ALLK
| $568K | ﹤0.01% |
869,969
-264,049
| -23% | -$191K |
|
|
FNA
3604
DELISTED
Paragon 28, Inc.
FNA
| $567K | ﹤0.01% |
84,812
+54,591
| +181% | +$413K |
|
3605
Genesco
GCO
$425M
| $563K | ﹤0.01% |
20,730
+10,521
| +103% | +$292K |
|
3606
Tejon Ranch
TRC
$457M
| $563K | ﹤0.01% |
32,072
+24,015
| +298% | +$427K |
|
3607
Designer Brands
DBI
$307M
| $560K | ﹤0.01% |
75,928
-29,446
| -28% | -$206K |
|
3608
Radiant Logistics
RLGT
$386M
| $558K | ﹤0.01% |
86,842
+32,556
| +60% | +$198K |
|
3609
iShares US Medical Devices ETF
IHI
$3.13B
| $558K | ﹤0.01% |
9,421
-145,472
| -94% | -$8.31M |
|
3610
Lindblad Expeditions
LIND
$1.94B
| $557K | ﹤0.01% |
60,234
+43,671
| +264% | +$406K |
|
3611
Willis Lease Finance
WLFC
$1.7B
| $556K | ﹤0.01% |
11,214
+7,728
| +222% | +$254K |
|
3612
Consensus Cloud Solutions
CCSI
$670M
| $556K | ﹤0.01% |
23,618
+17,333
| +276% | +$362K |
|
3613
Prudential
PUK
$37.6B
| $556K | ﹤0.01% |
+30,000
| New | +$524K |
|
3614
Urban One Class D
UONEK
$22.8M
| $556K | ﹤0.01% |
50,103
-9,648
| -16% | -$128K |
|
|
YSG
3615
Yatsen Holding
YSG
$322M
| $556K | ﹤0.01% |
162,969
| – | – |
|
3616
CALL
Rocket Pharmaceuticals
RCKT
$340M
| $554K | ﹤0.01% |
+30,000
| New | +$614K |
|
|
3617
PUT
Rocket Pharmaceuticals
RCKT
$340M
| $554K | ﹤0.01% |
+30,000
| New | +$614K |
|
|
ITIC
3618
Investors Title Co
ITIC
$546M
| $553K | ﹤0.01% |
2,406
+1,347
| +127% | +$283K |
|
3619
Ribbon Communications
RBBN
$377M
| $553K | ﹤0.01% |
170,110
+102,969
| +153% | +$334K |
|
3620
Capricor Therapeutics
CAPR
$223M
| $552K | ﹤0.01% |
36,296
+18,724
| +107% | +$92.6K |
|
|
CLCO
3621
DELISTED
Cool Company
CLCO
| $551K | ﹤0.01% |
48,791
+46,951
| +2,552% | +$546K |
|
3622
EVgo
EVGO
$223M
| $551K | ﹤0.01% |
132,981
+98,041
| +281% | +$375K |
|
3623
Lennar Class B
LEN.B
$19.4B
| $550K | ﹤0.01% |
3,347
-553
| -14% | -$84.3K |
|
3624
Corsair Gaming
CRSR
$1.13B
| $549K | ﹤0.01% |
78,933
+56,841
| +257% | +$425K |
|
3625
NVE Corp
NVEC
$562M
| $548K | ﹤0.01% |
6,863
+5,217
| +317% | +$414K |
|
Similar funds
Barclays's Q3 2024 Portfolio in Review
As of Q3 2024, Barclays held 5,593 positions worth $377B, up 15% from $327B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $31.3B of net new capital in Q3 2024, opening 785 new positions and adding to 2,954 existing holdings. Its largest new stake was Smurfit Westrock: 3,460,710 shares worth $171M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $2.06B trimmed.
- Barclays's largest Q3 2024 buy was Smurfit Westrock: 3,460,710 shares worth $171M.
- Barclays added most to iShares US Real Estate ETF in Q3 2024, an estimated $947M increase.
- Barclays's biggest Q3 2024 reduction was CRH, cutting an estimated $2.06B.
- Barclays fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $51.3M.
- Barclays's ten largest holdings make up 41% of its $377B portfolio in Q3 2024.
- Barclays opened 785 new positions and closed 322 in Q3 2024.
- Barclays's portfolio value rose 15% quarter-over-quarter to $377B.
Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.